Market Tracker

07/24 6:05pm ET

Novavax Inc (NASDAQ:NVAX)

4.47
Data as of Jul 24
 -0.07 / -1.54%
Today’s Change
2.24
Today|||52-Week Range
6.95
-12.70%
Year-to-Date
No recent news for Novavax Inc.

Today’s Trading

Previous close4.54
Today’s open4.56
Day’s range4.45 - 4.59
Volume1,957,745
Average volume (3 months)4,122,945
Market cap$1.1B
Dividend yield--
Data as of 4:00pm ET, 07/24/2014

Growth & Valuation

Earnings growth (last year)-40.91%
Earnings growth (this year)+16.77%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-5.26%
P/E ratioNM
Price/Sales41.53
Price/Book4.66

Competitors

 Today’s
change
Today’s
% change
HALOHalozyme Therapeutic...-0.09-0.97%
IMGNImmunoGen Inc-0.49-4.31%
BLUEbluebird bio Inc-0.01-0.03%
KITEKite Pharma Inc-0.41-1.72%
Data as of 4:00pm ET, 07/24/2014

Financials

Next reporting dateAugust 8, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$20.9M
Annual profit (last year)-$52.0M
Net profit margin-248.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
SVP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts